- Home
- CRVO vs BUUU Comparison
CRVO vs BUUU Comparison
Compare CRVO & BUUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- BUUU
- Stock Information
- Founded
- CRVO 2001
- BUUU 2017
- Country
- CRVO United States
- BUUU Hong Kong
- Employees
- CRVO N/A
- BUUU N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- BUUU Services-Misc. Amusement & Recreation
- Sector
- CRVO Health Care
- BUUU Consumer Discretionary
- Exchange
- CRVO Nasdaq
- BUUU Nasdaq
- Market Cap
- CRVO 65.2M
- BUUU 68.1M
- IPO Year
- CRVO N/A
- BUUU 2025
- Fundamental
- Price
- CRVO $7.58
- BUUU $8.30
- Analyst Decision
- CRVO Strong Buy
- BUUU
- Analyst Count
- CRVO 6
- BUUU 0
- Target Price
- CRVO $21.50
- BUUU N/A
- AVG Volume (30 Days)
- CRVO 64.4K
- BUUU 41.0K
- Earning Date
- CRVO 11-10-2025
- BUUU 11-28-2025
- Dividend Yield
- CRVO N/A
- BUUU N/A
- EPS Growth
- CRVO N/A
- BUUU N/A
- EPS
- CRVO N/A
- BUUU 0.05
- Revenue
- CRVO $6,159,786.00
- BUUU $6,328,425.00
- Revenue This Year
- CRVO N/A
- BUUU N/A
- Revenue Next Year
- CRVO N/A
- BUUU N/A
- P/E Ratio
- CRVO N/A
- BUUU $152.76
- Revenue Growth
- CRVO N/A
- BUUU 8.88
- 52 Week Low
- CRVO $1.80
- BUUU $3.67
- 52 Week High
- CRVO $16.94
- BUUU $9.50
- Technical
- Relative Strength Index (RSI)
- CRVO 54.12
- BUUU N/A
- Support Level
- CRVO $6.56
- BUUU N/A
- Resistance Level
- CRVO $7.80
- BUUU N/A
- Average True Range (ATR)
- CRVO 0.46
- BUUU 0.00
- MACD
- CRVO 0.11
- BUUU 0.00
- Stochastic Oscillator
- CRVO 87.86
- BUUU 0.00
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.